Mark Corbet MacRae Randall
Amministratore Delegato presso Commander Asset Management (Middle East) Ltd.
Profilo
Mr. Mark C.
Randall is Chief Executive Officer at Commander Asset Management (Middle East) Ltd.
and Commander Asset Management Ltd.
He and the team formed Commander Asset Management in 2002.
After leaving the Royal Navy, Mr. Randall joined the London office of Bank Sarasin in 1985 and during his 17 year tenure, he held multiple positions within the company.
In 1994, he became an Executive Director before assuming the position of Managing Director.
This role included managing and advising Institutional funds and being responsible for all international securities trading for the Bank Sarasin Group.
He was also founding Chairman of the Acorn Alternative Strategies Overseas Ltd, a Hedge Fund of Fund company which had assets under management in excess of Chf 500 million.
He has held and continues to hold Non-Executive Director roles in both private and publicly quoted companies.
Posizioni attive di Mark Corbet MacRae Randall
Società | Posizione | Inizio |
---|---|---|
Commander Asset Management (Middle East) Ltd. | Amministratore Delegato | 01/05/2002 |
Commander Asset Management Ltd.
Commander Asset Management Ltd. Investment ManagersFinance Commander Asset Management Ltd. (CommanderAM) is an alternative investment firm headquartered in London, UK. The firm was founded by Mark Randall, Timothy Tatham, and James Rolfe in 2002. CommanderAM provides bespoke solutions to institutional investors and other financial institutions to manage or advise segregated accounts, funds, and indexes. | Amministratore Delegato | 01/01/2002 |
Precedenti posizioni note di Mark Corbet MacRae Randall
Società | Posizione | Fine |
---|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Direttore/Membro del Consiglio | 04/04/2013 |
Sarasin International Securities Ltd. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Commander Asset Management (Middle East) Ltd. | |
Sarasin International Securities Ltd. | Finance |
Commander Asset Management Ltd.
Commander Asset Management Ltd. Investment ManagersFinance Commander Asset Management Ltd. (CommanderAM) is an alternative investment firm headquartered in London, UK. The firm was founded by Mark Randall, Timothy Tatham, and James Rolfe in 2002. CommanderAM provides bespoke solutions to institutional investors and other financial institutions to manage or advise segregated accounts, funds, and indexes. | Finance |
- Borsa valori
- Insiders
- Mark Corbet MacRae Randall